Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)

NCT02491073 · clinicaltrials.gov ↗

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsy

Interventions

OTHER: blood draw

Sponsor

Sumitomo Pharma America, Inc.